19.02.2024 – 17:05Helmholtz MunichWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and ComplicationsLearn more about research at Helmholtz Munichmore
18.01.2024 – 10:00PNO Innovation GmbH2OPTIMA cancer project announces the Region Uppsala as new partnerCheck out the OPTIMA Videomore
12.10.2023 – 14:01PNO Innovation GmbH3EU Provides 1 Mio. to Researchers to Advance Personalised OncologycanSERV CallOne documentmore
07.09.2023 – 08:38OD-OS GmbHOD-OS GmbH at ESCRS 2023: Recent MDR certification of Navilas® underlines its advanced standard in retina lasers and opens path to new developmentsmore
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsOne documentmore
08.08.2023 – 08:00PNO Innovation GmbH4PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data SetsMore about PIONEERmore
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmore
23.03.2023 – 12:04hubergroup Deutschland GmbH5Press Release - hubergroup India expands its support for rural healthcareMore about hubergroupOne documentmore
09.03.2023 – 10:00Medias Klinikum GmbH & Co KGThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remissionmore
08.02.2023 – 13:26BrainRepair UGBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully fundedmore
09.11.2022 – 10:39RHEACELL GmbH und Co. KGStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa researchmore
25.10.2022 – 09:00Metrics in BalanceMetrics in Balance und DNA Talks schließen sich zusammen und betreten den europäischen Lifestyle-Markt unter einem neuen Namen: LifeTalksmore
20.10.2022 – 12:00Klinik für Prostata-Therapie HeidelbergFocal therapy for prostate cancer: Reliable diagnosis leads to gentle treatmentmore
22.03.2022 – 14:00Lemon from SpainThree benefits that make lemon a key food in the Mediterranean dietmore
19.01.2022 – 12:51News DirectALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERSmore
17.12.2021 – 11:35EvoCare Holding AGDigital health platform helps to expand conventional medical services / EvoCare invites investors to support global roll-outmore
08.11.2021 – 14:17SYNformulas GmbHCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalizationmore
20.10.2021 – 16:30Sysmex Inostics GmbHNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inosticsmore
04.10.2021 – 11:25News Direct2#Artificial Intelligence in Healthcare - Sim&Cure Announces the Appointment of Dan Raffi as Chief Operating Officer and Board Membermore
01.07.2021 – 16:04News Direct3Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Accessmore
27.05.2021 – 10:35BrainRepair UGInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15Mmore
13.04.2021 – 14:04Fördergesellschaft IZB mbH2Lindis Biotech develops immunotherapy against bladder cancerIn the IZB you can find over 50 biotech start-upsOne documentmore
02.03.2021 – 14:36B. Braun Melsungen AG2B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®more
03.02.2021 – 13:30Fördergesellschaft IZB mbH3World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic toolsIn the IZB you can find over 50 biotech start-upsOne documentmore
30.09.2020 – 13:00BrainRepair UGRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Planmore
04.06.2020 – 14:16SYNformulas GmbH2Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipationmore
11.03.2020 – 09:30Hitachi Medical Systems Europe Holding AGHitachi Medical Systems Europe launches "ARIETTA 750", the new model from the ARIETTA series of diagnostic ultrasound platforms / This model inherited premium class technologiesmore
20.02.2020 – 17:51Fördergesellschaft IZB mbHInspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZBIn the IZB you can find over 50 biotech start-upsOne documentmore